SA520420037B1 - مركب حلقي من ميثيل لاكتام واستخدامه صيدلانيًا - Google Patents
مركب حلقي من ميثيل لاكتام واستخدامه صيدلانيًاInfo
- Publication number
- SA520420037B1 SA520420037B1 SA520420037A SA520420037A SA520420037B1 SA 520420037 B1 SA520420037 B1 SA 520420037B1 SA 520420037 A SA520420037 A SA 520420037A SA 520420037 A SA520420037 A SA 520420037A SA 520420037 B1 SA520420037 B1 SA 520420037B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- pharmaceutical use
- cyclic compound
- methyl lactam
- lactam
- methyl
- Prior art date
Links
- 150000001923 cyclic compounds Chemical class 0.000 title 1
- -1 methyl lactam Chemical class 0.000 title 1
- 108091006277 SLC5A1 Proteins 0.000 abstract 2
- 102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018036307 | 2018-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SA520420037B1 true SA520420037B1 (ar) | 2024-07-28 |
Family
ID=67806229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SA520420037A SA520420037B1 (ar) | 2018-03-01 | 2020-08-24 | مركب حلقي من ميثيل لاكتام واستخدامه صيدلانيًا |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11014910B2 (enExample) |
| EP (1) | EP3760624A4 (enExample) |
| JP (3) | JP7206132B2 (enExample) |
| KR (1) | KR102795351B1 (enExample) |
| CN (1) | CN111757877B (enExample) |
| AR (1) | AR114418A1 (enExample) |
| AU (1) | AU2019227770B2 (enExample) |
| BR (1) | BR112020016788A2 (enExample) |
| CA (1) | CA3087859A1 (enExample) |
| CL (1) | CL2020002199A1 (enExample) |
| IL (1) | IL276311B2 (enExample) |
| MA (1) | MA52427A (enExample) |
| MX (1) | MX2020009070A (enExample) |
| MY (1) | MY205197A (enExample) |
| PE (1) | PE20210123A1 (enExample) |
| PH (1) | PH12020551340A1 (enExample) |
| SA (1) | SA520420037B1 (enExample) |
| SG (1) | SG11202007120UA (enExample) |
| TW (1) | TWI805699B (enExample) |
| WO (1) | WO2019168096A1 (enExample) |
| ZA (1) | ZA202004600B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI805699B (zh) * | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| CN111902408B (zh) | 2018-04-04 | 2023-11-14 | 日本烟草产业株式会社 | 杂芳基取代的吡唑化合物及其药物用途 |
| CA3151909A1 (en) * | 2019-09-04 | 2021-03-11 | Japan Tobacco Inc. | Therapeutic or prophylactic method for diabetes using combination medicine |
| JPWO2021187548A1 (enExample) * | 2020-03-19 | 2021-09-23 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657282A (en) * | 1969-01-23 | 1972-04-18 | Merck & Co Inc | Carboxyepoxyethyl-1-phosphonic acid and derivatives |
| FR2665898B1 (fr) | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| JPH04247081A (ja) | 1991-02-01 | 1992-09-03 | Takeda Chem Ind Ltd | ５員複素環酸アミド類 |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| CA2515119A1 (en) | 2003-02-07 | 2004-08-19 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivative |
| AU2004200420A1 (en) | 2003-03-11 | 2004-09-30 | Astellas Pharma Inc. | Inhibitor of cyclooxygenase |
| JP2006182648A (ja) | 2003-04-08 | 2006-07-13 | Dai Ichi Seiyaku Co Ltd | ７員複素環誘導体 |
| US20050075375A1 (en) | 2003-05-14 | 2005-04-07 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis C virus |
| TW200526588A (en) | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
| TW200526641A (en) | 2003-12-26 | 2005-08-16 | Daiichi Seiyaku Co | Amidopyrazole derivatives |
| CN1980665A (zh) | 2004-07-07 | 2007-06-13 | 默克公司 | 吡唑酰胺衍生物，包含这些化合物的组合物和使用方法 |
| EP1811983B1 (en) | 2004-11-16 | 2020-10-07 | GW Pharma Limited | New use for cannabinoid |
| JP2008007405A (ja) | 2004-12-07 | 2008-01-17 | Takeda Chem Ind Ltd | カルボキサミド誘導体 |
| CN101243074A (zh) * | 2005-06-08 | 2008-08-13 | 日本烟草产业株式会社 | 杂环化合物 |
| WO2006132436A1 (ja) | 2005-06-08 | 2006-12-14 | Japan Tobacco Inc. | 複素環化合物 |
| JP4137956B2 (ja) * | 2005-06-08 | 2008-08-20 | 日本たばこ産業株式会社 | 複素環化合物 |
| WO2007034279A2 (en) * | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | C3a antagonists and pharmaceutical compositions thereof |
| JP2009523748A (ja) | 2006-01-18 | 2009-06-25 | シエナ ビオテク ソシエタ ペル アチオニ | α７ニコチン性アセチルコリン受容体の調節物質およびそれらの治療への使用 |
| EP2026798A1 (en) * | 2006-04-27 | 2009-02-25 | Solvay Pharmaceuticals GmbH | Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators |
| US20080027014A1 (en) | 2006-07-28 | 2008-01-31 | Tanabe Seiyaku Co., Ltd. | Novel SGLT inhibitors |
| KR101450356B1 (ko) | 2006-11-24 | 2014-10-15 | 에이씨 이뮨 에스.에이. | 알츠하이머와 같은 아밀로이드 또는 아밀로이드-유사 단백질과 관련된 질환의 치료를 위한 ｎ-(메틸)-1ｈ-피라졸-3-아민, ｎ-(메틸)-피리딘-2-아민 및 ｎ-(메틸)-티아졸-2-아민 유도체 |
| WO2008061796A2 (en) | 2006-11-24 | 2008-05-29 | Ac Immune Sa | Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| KR101506935B1 (ko) * | 2007-04-02 | 2015-03-31 | 테라코스, 인코포레이티드 | 벤질릭 글리코시드 유도체 및 사용 방법 |
| US20090181952A1 (en) | 2008-01-14 | 2009-07-16 | Wyeth | Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
| TW201006832A (en) | 2008-07-15 | 2010-02-16 | Novartis Ag | Organic compounds |
| RU2017144535A (ru) | 2010-03-30 | 2019-02-18 | Версеон Корпорейшн | Мультизамещенные ароматические соединения в качестве ингибиторов тромбина |
| AR087701A1 (es) * | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| TWI805699B (zh) * | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
| CN111902408B (zh) | 2018-04-04 | 2023-11-14 | 日本烟草产业株式会社 | 杂芳基取代的吡唑化合物及其药物用途 |
-
2019
- 2019-02-27 TW TW108106807A patent/TWI805699B/zh active
- 2019-02-28 EP EP19760111.5A patent/EP3760624A4/en active Pending
- 2019-02-28 CN CN201980016238.4A patent/CN111757877B/zh active Active
- 2019-02-28 AU AU2019227770A patent/AU2019227770B2/en active Active
- 2019-02-28 AR ARP190100503A patent/AR114418A1/es unknown
- 2019-02-28 MX MX2020009070A patent/MX2020009070A/es unknown
- 2019-02-28 MA MA052427A patent/MA52427A/fr unknown
- 2019-02-28 CA CA3087859A patent/CA3087859A1/en active Pending
- 2019-02-28 US US16/289,500 patent/US11014910B2/en active Active
- 2019-02-28 MY MYPI2020003891A patent/MY205197A/en unknown
- 2019-02-28 BR BR112020016788-6A patent/BR112020016788A2/pt unknown
- 2019-02-28 KR KR1020207025856A patent/KR102795351B1/ko active Active
- 2019-02-28 IL IL276311A patent/IL276311B2/en unknown
- 2019-02-28 PE PE2020001287A patent/PE20210123A1/es unknown
- 2019-02-28 WO PCT/JP2019/007799 patent/WO2019168096A1/ja not_active Ceased
- 2019-02-28 SG SG11202007120UA patent/SG11202007120UA/en unknown
- 2019-02-28 JP JP2019035140A patent/JP7206132B2/ja active Active
-
2020
- 2020-07-24 ZA ZA2020/04600A patent/ZA202004600B/en unknown
- 2020-08-24 SA SA520420037A patent/SA520420037B1/ar unknown
- 2020-08-26 CL CL2020002199A patent/CL2020002199A1/es unknown
- 2020-08-27 PH PH12020551340A patent/PH12020551340A1/en unknown
-
2021
- 2021-04-16 US US17/233,273 patent/US20220064148A1/en not_active Abandoned
-
2023
- 2023-01-04 JP JP2023000037A patent/JP2023026566A/ja active Pending
- 2023-06-28 US US18/343,415 patent/US20240174646A1/en not_active Abandoned
-
2024
- 2024-12-09 JP JP2024214451A patent/JP2025026615A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA520420037B1 (ar) | مركب حلقي من ميثيل لاكتام واستخدامه صيدلانيًا | |
| PH12020551821A1 (en) | Novel compounds | |
| MX2022006783A (es) | Nuevos derivados de metilquinazolinona. | |
| SA521422143B1 (ar) | 15-pgdh مثبط | |
| EA202090573A1 (ru) | Составы нирапариба | |
| MX2021004457A (es) | Composicion farmaceutica para administracion oral que comprende derivado de aminopirimidina o su sal. | |
| EA201692300A1 (ru) | Производные карбоксамида | |
| EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
| BR112022020933A2 (pt) | Inibidores de replicação do vírus da imunodeficiência humana | |
| EA202190316A1 (ru) | Конденсированное производное лактама | |
| PH12020551341A1 (en) | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof | |
| PH12020550763A1 (en) | Pyridinone derivatives and their use as selective alk-2 inhibitors | |
| MX379373B (es) | Derivado de sulfonamida heterocíclico y medicina que contiene el mismo. | |
| EA202190064A1 (ru) | Цианотриазоловые соединения и варианты их применения | |
| EA202090995A1 (ru) | Полициклические амиды в качестве положительных аллостерических модуляторов мускариновых рецепторов м1 | |
| EA202092814A1 (ru) | Пиридоновое производное, его композиция и применение в качестве противовирусного лекарственного средства | |
| EA202090925A1 (ru) | Гетероарильные соединения в качестве позитивных аллостерических модуляторов мускаринового рецептора m1 | |
| MX381234B (es) | Agente preventivo y/o terapéutico de enfermedad inmune. | |
| GEP20257771B (en) | Compounds and compositions as sppl2a inhibitors | |
| FI3433257T3 (fi) | Alkynyylinukleosidianalogeja ihmisen rinoviruksen estäjinä | |
| JOP20220084A1 (ar) | مشتقات 5-أوكسا- 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4 | |
| CL2024001073A1 (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
| MX2022004912A (es) | Novedoso compuesto de anillo condensado sustituido. | |
| PH12019502261A1 (en) | Therapeutic or prophylactic agent for peripheral neuropathies | |
| MX2019015478A (es) | Una nanosuspension farmaceutica para el tratamiento de infeccion por vih. |